ABVX

Conviction 22HealthcareScan · Thu, Jun 25, 2026

ABVX$92.36-0.16%

ResistanceSupportVol 14

Vol MA14 2.04M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Abivax S.A.Biotechnologywww.abivax.com ↗

Price92.36

Change-0.16%

Gap-2.56%

Rel volume0.37×

Avg volume3.42M

Avg $ vol330.76M

SMA 20102.03

SMA 50112.06

SMA 200111.17

Price vs 50-17.58%

Price vs 200-16.92%

MA stackmixed

50/200 cross—

Supertrenddown · 110.15

RSI (14)40

MACD hist-0.33

MACD crossbear · 1d

Stoch %K / %D53 / 57

ADX (14)20

+DI / −DI16 / 35

RSI divergence—

MACD divergence—

ATR %+9.70%

ADR %8.27%

52w high145.31

52w low7.05

From 52w high-36.44%

Above 52w low+1210.07%

New 52w highNo

SqueezeOff

Bollinger width53.82%

%B0.32

Donchian pos34.55%

Donchian high135.08

Donchian low69.81

AVWAP (52w high)111.59

vs AVWAP high-17.23%

AVWAP (52w low)97.66

vs AVWAP low-5.42%

OBV trendDown

Chaikin MF (20)-0.03

Today vs 20d0.37×

Avg vol (14d)2.04M

Avg vol (20d)3.42M

Avg $ vol (20d)330.76M

Market cap7.25B

RS 3m (vs SPY)-28.29%

RS 6m (vs SPY)-27.25%

RS line new highNo

Trend template3/8

Technical rank12.6

1 week-7.78%

1 month-26.94%

3 months-16.57%

6 months-33.42%

1 year+1288.87%

YTD-30.96%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target143.17

Target upside55.01%

Analyst ratingBuy

Institutional63.36%

Ent. value7.25B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out79.77M

Employees69

ListedFri, Oct 20, 2023

Free float58.23M

Float %73.1%

Short interest3.05M

Days to cover2.5d

Short volume33.4%

Squeeze score23 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.71 vs −$1.07

Last surprise+33.6% beat

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank12.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance132.13

Support82.76

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in ABVX

All disclosures →

No recent disclosed trades by Congress in ABVX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ABVX

No recent insider (Form 4) filings in ABVX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ABVX · 1 recent

EDGAR →

8-K6-KTue, Jun 2, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.